David Hung - Net Worth and Insider Trading

David Hung Net Worth

The estimated net worth of David Hung is at least $138 Million dollars as of 2024-03-19. David Hung is the President and CEO of Medivation Inc and owns about 1,694,309 shares of Medivation Inc (MDVN) stock worth over $138 Million. David Hung is also the Principal Executive Officer of Sio Gene Therapies Inc and owns about 67,422 shares of Sio Gene Therapies Inc (SIOX) stock worth over $32,228. Details can be seen in David Hung's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David Hung has not made any transactions after 2017-04-17 and currently still holds the listed stock(s).

Transaction Summary of David Hung

To

David Hung Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David Hung owns 7 companies in total, including ARYA Sciences Acquisition Corp () , NovoCure Ltd () , and Establishment Labs Holdings Inc () among others .

Click here to see the complete history of David Hung’s form 4 insider trades.

Insider Ownership Summary of David Hung

Ticker Comapny Transaction Date Type of Owner
ARYA Sciences Acquisition Corp 2020-07-01 director
NovoCure Ltd 2018-05-31 director
Establishment Labs Holdings Inc 2018-07-18 director
Sio Gene Therapies Inc 2017-12-29 director & Principal Executive Officer
Medivation Inc 2016-09-28 director & President and CEO
Acer Therapeutics Inc 2011-04-05 director
Nuvation Bio Inc 2021-02-10 director & 10 percent owner & President and CEO

David Hung Latest Holdings Summary

David Hung currently owns a total of 2 stocks. Among these stocks, David Hung owns 1,694,309 shares of Medivation Inc (MDVN) as of March 4, 2016, with a value of $138 Million and a weighting of 99.98%. David Hung also owns 67,422 shares of Sio Gene Therapies Inc (SIOX) as of April 17, 2017, with a value of $32,228 and a weighting of 0.02%.

Latest Holdings of David Hung

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MDVN Medivation Inc 2016-03-04 1,694,309 81.44 137,984,525
SIOX Sio Gene Therapies Inc 2017-04-17 67,422 0.48 32,228

Holding Weightings of David Hung


David Hung Form 4 Trading Tracker

According to the SEC Form 4 filings, David Hung has made a total of 0 transactions in Medivation Inc (MDVN) over the past 5 years. The most-recent trade in Medivation Inc is the sale of 5,085 shares on March 4, 2016, which brought David Hung around $208,994.

According to the SEC Form 4 filings, David Hung has made a total of 0 transactions in Sio Gene Therapies Inc (SIOX) over the past 5 years. The most-recent trade in Sio Gene Therapies Inc is the acquisition of 67,422 shares on April 17, 2017, which cost David Hung around $10 Million.

Insider Trading History of David Hung

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David Hung Trading Performance

GuruFocus tracks the stock performance after each of David Hung's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Hung is 10.09%. GuruFocus also compares David Hung's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Hung within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how David Hung's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of David Hung

Average Relative Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) -0.42 10.09 -70.88 -94.51 -78.01 -72.01
Relative Return to S&P 500(%) -0.76 5.4 -79.83 -109.72 -89.13 -78.97

David Hung Ownership Network

Ownership Network List of David Hung

No Data

Ownership Network Relation of David Hung


David Hung Owned Company Details

What does ARYA Sciences Acquisition Corp do?

Who are the key executives at ARYA Sciences Acquisition Corp?

David Hung is the director of ARYA Sciences Acquisition Corp. Other key executives at ARYA Sciences Acquisition Corp include director & Chief Executive Officer Adam Leo Stone , and director & Chief Financial Officer Michael Seth Altman .

ARYA Sciences Acquisition Corp () Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ARYA Sciences Acquisition Corp () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARYA Sciences Acquisition Corp () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ARYA Sciences Acquisition Corp ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ARYA Sciences Acquisition Corp Insider Transactions

No Available Data

David Hung Mailing Address

Above is the net worth, insider trading, and ownership report for David Hung. You might contact David Hung via mailing address: C/o Axovant Sciences, Inc., 320 West 37th Street, 5th Floor, New York Ny 10018.

Discussions on David Hung

No discussions yet.